Browsing by Subject "chimeric antigen receptor (CAR) T cell"
Now showing items 1-1 of 1
-
Current progress in chimeric antigen receptor T cell therapy for glioblastoma multiforme
( John Wiley and Sons Inc , 2021 , Article)Glioblastoma multiforme (GBM) is one of the deadliest brain tumors with an unfavorable prognosis and overall survival of approximately 20 months following diagnosis. The current treatment for GBM includes surgical resections ...